2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theWhole Genome And Exome Sequencing Market?

The burgeoning requirement for customized medical treatment is predicted to drive the expansion of the whole genome and exome sequencing market moving forward. This tailor-made approach to medicare pivots on individualized healthcare choices and intervention strategies, resting on unique aspects like the patient’s genetic makeup, environment, and way of life. Whole genome and exome sequencing play a critical role in these proceedings by offering an in-depth analysis of a patient’s genetic profile, enabling bespoke health plans and interventions based on distinctive genetic, environmental, and lifestyle factors. To illustrate, the Personalized Medicine Coalition (PMC), an advocacy group in the US promoting comprehension and implementation of personalized medicine, projected in October 2022 that over 75,000 genetic testing products and 300 personalized medicines would hit the market in 2022. Adding to this, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) gave the green light to 37 new molecular entities (NMEs) in 2022. Additionally, among the 35 therapeutic NMEs, roughly 34% – 12 in number – are earmarked as personalized. This uptick in the demand for personalized medicine, therefore, is fuelling the growth of the whole genome and exome sequencing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

#What Growth Opportunities Will Drive the Whole Genome And Exome Sequencing Market’s CAGR Through 2034?

The market size for genome and exome sequencing has been experiencing significant growth over recent years. It is expected to expand from a value of $2.02 billion in 2024 to $2.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 24.8%. Factors contributing to growth during the historical period include declining sequencing costs, increased incidence of genetic disorders, clinical use, development of genomic databases, and innovations in bioinformatics.

The market for whole genome and exome sequencing is predicted to experience a significant upsurge in the coming years, with a size projected to reach $6.14 billion in 2029, boasting a compound annual growth rate (CAGR) of 24.9%. Factors contributing to the anticipated growth during the forecast period include initiatives in population genomics, an increasing demand for precision medicine, advancements in single-cell sequencing, expanding scope of non-invasive prenatal testing (NIPT), and its application in researching rare diseases. The forecast period is also expected to see prevalent trends such as increased clinical adoption, rapid progress in sequencing technologies, the advent of population-scale genomic studies, integration of technologies like artificial intelligence (AI) and machine learning (ML), and burgeoning applications in oncology.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

What Key Market Trends and Innovations Are Shaping the Future of theWhole Genome And Exome Sequencing Industry?

To remain competitive in the whole genome and exome sequencing markets, leading companies are putting their efforts into creating highly advanced technological solutions such as ultra-fast NGS analysis. This innovative technology allows for the management of next-generation sequencing data with unprecedented speed, substantially decreasing the amount of time necessary for genomic data analysis. For example, QIAGEN Digital Insights (QDI), a bioinformatics firm based in the US, introduced an ultra-fast NGS analysis platform in January 2023. Notably, this platform can process an entire genome in 25 minutes at a cloud computing cost of $1, offering efficiency, affordability, and scalability. This technological breakthrough significantly increases the speed and accessibility of genomic data analysis, making it particularly relevant in the whole genome and exome sequencing market. It enables quicker decision making and broader adoption of personalized medicine.

Which Companies Are Leading the Charge in Expanding theWhole Genome And Exome Sequencing Market Growth?

Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

How is the Global Whole Genome And Exome Sequencing Market Segemented?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp

Which Geographics are Influencing the Growth of the Whole Genome And Exome Sequencing Market?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Whole Genome And Exome Sequencing Market 2025, By The Business Research Company:

Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Prenatal DNA Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: